Will BEAM-101 receive FDA approval for sickle cell therapy by end of 2025?

Will Blenrep re-enter the US market by December 31, 2025?

Will Beam Therapeutics' stock increase by more than 20% by March 31, 2025?

Which major pharma company will partner with Beam Therapeutics by end of 2025?

Will BEAM-101 outperform Reni-cel and Casgevy in clinical trials by end of 2025?

Amgen stock price increase by 10% post-ASH24 by January 8, 2025?

FDA approval for expanded use of BLINCYTO® in pediatric B-cell ALL by end of 2025?

Major pharmaceutical partnership with Amgen for BLINCYTO® by mid-2025?

Blenrep's global market share in multiple myeloma treatments by December 31, 2025

Will China's NMPA approve Blenrep combination therapy by June 30, 2025?

Will further positive results from the DREAMM-7 trial be published by December 31, 2025?

Outcome of Blenrep's priority review by China's NMPA by December 31, 2025

GSK stock price change within a week of Blenrep's approval in China

Which therapy will lead the market share for sickle cell treatment by end of 2025?

Where will BEAM-101 be approved by end of 2025?

BLINCYTO® sales growth in the first half of 2025?

First major medical journal to feature AALL1731 trial results by March 2025?

First region to approve BLINCYTO® for pediatric B-cell ALL post-ASH24 by end of 2025?